Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

temporary image

Liming Yang, Ph.D.

  • Team Lead

Dr. Liming Yang has expertise in cancer genomics and molecular characterizations in clinical trials and genomic data analysis. He also has special interests in new molecular characterization and analysis technologies and data sharing policies. 

Dr. Yang is also the Contracting Officer's Representative (COR) for the Genomics Characterization Centers (GCCs) and Genomic Data Commons (GDC), which are components of the NCI Genome Characterization Pipeline. 

 

Background

Dr. Yang's background includes pathology and bioinformatics. Before the NCI Center for Cancer Genomics was integrated into DCB, he worked there as a team lead and the Program Director for the Genomic Data Analysis Network (GDAN).

 

Education

  • Ph.D., Pathology University of Utah
  • Updated:
Email